HOXB8 and pneumococcal meningitis: Recently, using the HoxB8 system as well as in vivo in experimental pneumococcal meningitis, we and others demonstrated that, in the presence of E. coli-derived LPSs or in the context of E. coli or Streptococcus pneumoniae infection, the survival of PMNs was extended [12,13].